HPV vaccination in France: uptake, costs and issues for the National Health Insurance

JP Fagot, A Boutrelle, P Ricordeau, A Weill… - Vaccine, 2011 - Elsevier
INTRODUCTION: Two vaccines for primary prevention of cervical cancer are available in
France, Gardasil® and Cervarix®, since 2007 and 2008 respectively. Currently, the French …

A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer

N Demarteau, B Detournay, B Tehard… - International journal of …, 2011 - Springer
Objective This study aimed at evaluating the cost-effectiveness of human papillomavirus
virus (HPV) vaccination in France, using a generally applicable succinct cohort model …

Effectiveness of HPV vaccination in women reaching screening age in Italy

FM Carozzi, C Ocello, E Burroni, H Faust… - Journal of Clinical …, 2016 - Elsevier
Background and objectives A randomized trial was conducted in Tuscany, Italy, to evaluate
the effectiveness of HPV vaccination for 25 year old (yo) women who attend at the first time …

Efficacy of vaccination against HPV infections to prevent cervical cancer in France: present assessment and pathways to improve vaccination policies

L Ribassin-Majed, R Lounes, S Clémençon - PloS one, 2012 - journals.plos.org
Background Seventy percent of sexually active individuals will be infected with Human
Papillomavirus (HPV) during their lifetime. These infections are incriminated for almost all …

HPV vaccination for boys? A systematic review of economic studies

E Sinisgalli, I Bellini, L Indiani, A Sala… - Epidemiologia e …, 2015 - flore.unifi.it
INTRODUCTION: HPV vaccination is recommended in many countries, including Italy, for
girls in their twelfth year of age. In some countries, the goal of vaccination coverage has not …

Coverage and compliance of human papillomavirus vaccines in Paris: Demonstration of low compliance with non-school-based approaches

R Rouzier, JP Giordanella - Journal of adolescent health, 2010 - Elsevier
OBJECTIVE: To evaluate the coverage and compliance of the Human Papilloma Virus
(HPV) vaccine in Paris. METHODS: We selected a female population living in Paris …

Introduction of human papillomavirus vaccination in Belgium, Luxembourg and the Netherlands

M Arbyn, C Simoens, P Van Damme… - Gynecologic and …, 2010 - karger.com
Aims: To document progress with human papillomavirus (HPV) vaccine introduction in three
closely related European countries, one with organized (the Netherlands) and two with …

Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening

N Thiry, C De Laet, F Hulstaert, M Neyt… - International journal of …, 2009 - cambridge.org
Objectives: The cost-effectiveness of adding a human papillomavirus (HPV) vaccination
program in 12-year-old females to the recommended cervical cancer screening in Belgium …

[HTML][HTML] Human papillomavirus vaccines in Picardy, France: coverage and correlation with socioeconomic factors

O Ganry, AS Bernin-Mereau, M Gignon… - Revue d'épidémiologie …, 2013 - Elsevier
Abstract Background In France, the human papillomavirus vaccine is routinely
recommended for 14-year-old females and a “catch-up” vaccination should be offered to …

Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France

C Bergeron, N Largeron, R McAllister… - International journal of …, 2008 - cambridge.org
Objectives: A vaccine to prevent diseases due to human papillomavirus (HPV) types 6, 11,
16, and 18 is now available in France. The objective of this study was to assess the health …